Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation

Journal of Clinical Pathology

Volumn 49, Issue 10, 1996, Pages 853-856

  Harrison, P ^a   Neilson, J R ^a   Marwah, S S ^b   Madden, L ^b   Bareford, D ^b   Milligan, D W ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Acute leukaemia; Bone marrow transplantation; Liver dysfunction; Non transferrin bound iron

Indexed keywords

ASPARTATE AMINOTRANSFERASE; FERRITIN; TRANSFERRIN;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; IRON OVERLOAD; LIVER DYSFUNCTION; PRIORITY JOURNAL; SERUM;

EID: 0029798791     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.10.853     Document Type: Article

References (25)

1. Armitage JO, Burns CP, Kent TH. Liver disease complicating the management of acute leukaemia during remission. Cancer 1978;41:737-42
2. Aricò M, Maggiore G, Silini S, Bono F, Viganȯ C, Cerino A, et al. Hepatitis C infection in children treated for acute lymphoblastic leukaemia. Blood 1994;84:2919-22.
3. Binakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds). Graft-versus-host disease. New York: Dekker, 1990.
4. McDonald GB, Sharma P, Matheus DE, Schilman HM, Thomas ED. The clinical course of 53 patients with venoocclusive disease after marrow transplantation. Transplantation 1985;44:39:603-7.
5. Perry MC. Chemotheraputic agents and hepatotoxicity. Semin Oncol 1992;19:551-65.
6. McKay PJ, Murphy JA, Cameron S, Burnett AK, Campbell P, Tansey P, et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996;17:63-6.
7. Worwood M, Cragg SJ, Jacobs A, McLaren C, Ricketts C, Economidou J. Binding of serum ferritin to concanavalin A in patients with homozygous thalassaemia and transfusional iron overload. Br J Haematol 1980;46:409-16.
8. Worwood M, Dawkins S, Wagstaff M, Jacobs A. The purification and properties of ferritin from human serum. Biochem J 1976;157:97-103.
9. Bately RG, Lai Chung Fong P, Shamir S, Sherlock S. A non transferrin bound serum iron in idiopathic haemachromatosis. Dig Dis Sci 1980;25:340-6.
10. Harrison P, Marwah SS, Hughes RT, Bareford D. Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. J Clin Pathol 1994;47:350-2.
11. Halliwell B, Aruoma OI, Mufti G, Bomford A. Bleomycin-detectable iron in the serum from leukaemic patients before and after chemotherapy. FEBS Lett 1988;241:202-4.
12. Gutteridge JMC, Hou Y. Iron complexes and their reactivity in the bleomycin assay for radical promoting loosly bound iron. Free Radic Res 1986;2:143-51.
13. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterology 1975;68:525-33.
14. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990;336:1022-5.
15. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide dependant formation of hydroxyl radicals in the presence of iron salts. Biochem J 1981;199:263-5.
16. Von Hoff DD, Rozencweig M, Layard M, Slavic M, Muggia FM. Daunomycin-induced cardiotoxicity in children and adults: A review of 110 cases. Am J Med 1977;62:200-8.
17. Blum RH, Carter SK, Agre K. A clinical review of bleomycin a new antineoplastic agent. Cancer 1973;31: 903-14.
18. Livesey SJ, Holmes JA, Whittaker JA. Ocular complications of bone marrow transplantation. Eye 1989;3:271-6.
19. Kirk JA, Raghupathy P, Stevens MM, Towell CT, Menser MA, Bergin M, et al. Growth failure and growth hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1987;i:190-3.
20. Hetherington MJ, Buchanan GR. Elevated transaminase values during therapy for acute lymphoblastic leukaemia correlate with prior blood transfusions. Cancer 1988;62: 1614-18.
21. Locascuilli A, Gornati G, Tagger A, Ribero ML, Cavalletto D, Cavalletto L, et al. Hepatitis C virus infection and chronic liver disease in children with leukaemia in long term remission. Blood 1991;78:1619-22.
22. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
23. Kohlo E, Oksanen K, Honkanen F, Naukkarinen R, Krusius T. Hepatitis C antibodies in dialysis patients and patients with leukaemia. J Med Virol 1993;40:318-21.
24. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B. Low molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 1985;68:463-7.
25. Halliwell B. Superoxide-dependant formation of hydroxyl radicals in the presence of iron chelates. FEBS Lett 1978;92:321-6.